Update shared on 21 Dec 2025
Fair value Increased 11%Analysts have raised their price target on Axon Enterprise by roughly $60 to reflect stronger expected revenue growth and the company’s expanding addressable market, even as they temper long term margin and valuation assumptions.
Analyst Commentary
Recent research updates highlight a generally constructive view on Axon’s long term growth prospects, but they also surface a set of more cautious perspectives around valuation, execution, and the durability of current growth rates.
Several firms initiating coverage emphasize Axon’s expanding product portfolio, opportunities in artificial intelligence and drones, and a large, underpenetrated customer base across public safety and broader frontline workers. These themes support expectations for sustained mid twenties revenue growth and reinforce the view that the company operates in a sticky market with meaningful cross sell and up sell potential.
At the same time, the latest round of target changes and post earnings reactions show that not all market participants are prepared to underwrite the most optimistic scenarios, particularly given recent order trends and the stock’s prior re rating.
Bearish Takeaways
- Bearish analysts cutting price targets point to a disconnect between Axon’s mixed order performance and the premium multiple embedded in the shares, arguing that the valuation leaves limited room for execution missteps.
- The characterization of the latest quarter as mixed, with softer orders despite a constructive outlook, is cited as evidence that growth could prove lumpier than bulls expect, raising the risk of future estimate and target revisions.
- Cautious commentary stresses that, while end market demand remains solid, expectations for mid twenties revenue growth may already be fully reflected in the stock, creating downside risk if new product ramps or international expansion underdeliver.
- Some bearish analysts also flag that aggressive long term assumptions around Axon’s addressable market and newer initiatives, including advanced technologies, could be tested if adoption curves slow or competition intensifies, pressuring both growth and margin trajectories.
What's in the News
- Axon Enterprise raised its full year 2025 revenue guidance to approximately $2.74 billion, implying about 31% annual growth, up from a prior range of $2.65 billion to $2.73 billion (corporate guidance).
- The company issued fourth quarter 2025 revenue guidance of $750 million to $755 million, also representing roughly 31% year over year growth, signaling confidence in sustained demand across products and services (corporate guidance).
- Axon introduced the Axon Body Workforce Mini, a smaller, lighter body camera aimed at retail, healthcare, and other frontline workers, designed to address rising workplace violence and theft while integrating into Axon’s broader connected safety ecosystem (product announcement).
- The company reported that between July 1 and September 30, 2025, it did not repurchase additional shares, while confirming completion of 1,788,069 shares repurchased for $33.8 million, or about 3.35% of shares, under its long running buyback program announced in 2016 (buyback update).
Valuation Changes
- Fair Value has increased moderately, rising from approximately $579.32 to about $642.73 per share.
- Discount Rate has risen slightly, moving from roughly 7.14% to about 7.65%, which implies a marginally higher required return.
- Revenue Growth assumptions have increased modestly, from about 21.44% to roughly 23.31% annually.
- Net Profit Margin expectations have fallen significantly, declining from around 13.91% to approximately 4.55%.
- Future P/E has expanded substantially, moving from roughly 109.2x to about 315.9x, which indicates a much higher valuation multiple on projected earnings.
Have other thoughts on Axon Enterprise?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystLowTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystLowTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystLowTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
